|
|
|
Leap Chem Co., Ltdis a supplier of
|
 |
4 4 5 5 6 6 ....-heptadecafluoro-undecan |
|
|
This listing includes other chemicals and chemical products supplied by Leap Chem Co., Ltd.
Click the line at a product and you will get the email form to send an inquiry.
|
|
|
| Product names |
CAS numbers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Information on Leap Chem Co., Ltd |
LEAPChem, a specialized fine chemicals supplier for research, development and production.
LEAPChem provides nearly 5,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities.
As a highly customer-oriented enterprise, we are committed to providing high-quality customer services and products to our global customers in a cost-effective and efficient manner.
Our client list includes many major pharmaceutical and science companies, universities, research institutions and chemical catalogue companies.
Methodology: Sound and Stable;Active and Innovative.
Attitude: Conscientious; Ingenious.
Goals: Customer’s Satisfaction
We regard client’s success as our success.
At LEAPChem we strive to be the preferred supplier for efficiency increasing and cost lowering in your Research&Production.
To achieve this strategic vision, we always push ourself to exceed our customer's requirement. By focusing 'Beyond Your Expectation' we continually expand our product line, enhance our systematic management and human resources.
Welcome to contact us and we look forward to becoming your preferred partner.
|
|
Leap Chem Co., Ltd also offers: 3”-O-tert-Butyl-2'-deoxymugineic Acid tert-Butyl Diethyl Ester 3’-Mercaptoacetaminophen Disulfide 3’,5’-di-O-acetyl o6-benzyl-2’-deoxyguanosine 3’,4’-Diaminobutyrophenone 3{[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]thio}propanohydrazide 3]Triazol-5-amine 3[[(6-Chloro-3-pyridinyl methyl]methylamino]-2-buterenitrile 3[(3S)Piperidin-3-yl]3,4-dihydro-1H-2lambda(6),1,3benzothiadiazine-2,2-dione hydrochloride 3X flag peptide 3Tpymb , tris(2,4,6-trimethyl-3-(pyridin-3-yl)phenyl)borane 3S-6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole 3S-(3A,3a,6a)]-hexahydrofuro[2,3-b]furan-3-ol acetate 3S-(-)-3-[3-(Methanesulfonyl)phenyl]piperidine tartaric acid salt 3S,4S-Dihydroxy-3,4-dihydro-dibenzanthracene 3S,4S-4-Aminomethyl-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester 3S,4S)-1-Benzyl-3-methoxypiperidin-4-amine 3S,4R-4-[Phenyl-1-methylpiperidinyl] methanol 3S,4R-(4-tert-Butoxycarbonylamino-pyrrolidin-3-yl)-acetic acid ethyl ester 3S, 5S enantiomer of Atorvastatin calcium 3R-Methyl-2,3-dihydro-isoindol-1-one 3R,4S-4-[Phenyl-1-methylpiperidinyl] methanol 3R,4S-4-(4-Methoxyphenyl)-1-methylpiperi dinyl] methanol 3R,4S)-1-(tert-Butoxycarbonyl)-4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)piperidine-3-carboxylic acid 3R,4R-Dihydroxy-3,4-dihydro-dibenzanthracene 3R,4R)-(-)-1-Benzyl-3,4-pyrrolidindiol 3R enantiomer 3PO 3PO 3Phenylpropylbenzoate 3PGP2V 3Oumarin 525, dye content 3N-Benzyloxycarbonyl 3-amino-2,2-dimethylpropanamide 3N-(2'-Fluoroethyl)benperidol 3Methyl4nitrobiphenyl(3'-methyl-4-nitroisomericform) 3Methyl4dimethylaminoazobenzene(3-methylisomer) 3Mee2-8-en 3Iodo3nitrosalicylanilide 3Hhpc1 3H-[1,4]Diazepino[1,2-a]benzimidazole(8ci,9ci) 3H-[1,3]Dioxolo[4,5]furo[3,2-c]pyrazole 3H-[1,3]Dioxolo[4,5-g]oxazolo[4,3-a]isoquinolin-3-one, 5,6-dihydro-1-phenyl- 3H-[1,3]Dioxolo[4,5-g]oxazolo[4,3-a]isoquinolin-3-one, 1-(3,4-dimethoxyphenyl)-5,6-dihydro- 3H-[1,3]Dioxolo[4,5-g]oxazolo[4,3-a]isoquinolin-3-one, 1-(1,3-benzodioxol-5-yl)-1,5,6,11b-tetrahydro-, (1s-trans)- 3H-[1,3]Dioxolo[4,5-g]oxazolo[4,3-a]isoquinolin-3-one, 1-(1,3-benzodioxol-5-yl)-1,5,6,11b-tetrahydro-, (1r-cis)- 3H-[1,2]Oxathiolo[4,3-c]pyridine 3H-[1,2]Oxathiolo[3,4-b]pyridine 3H-[1,2,5]Oxadiazolo[3,4-e]oxazolo[3,2-a]pyrimidine 3H-[1,2,4]Triazepino[2,3-a]benzimidazol-4(5H)-one 3H-[1,2,4]Oxadiazolo[4,3-d][1,4]oxazepine 3H-[1,2,4]Oxadiazolo[4,3-c]pyrimidine
|
|
|
|
|
|
|
|